2-(p-Trifluormethylphenyl)-butan | 61628-76-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 2-(p-Trifluormethylphenyl)-butan
• 英文别名: 1-sec-butyl-4-(trifluoromethyl)benzene；Benzene, 1-(1-methylpropyl)-4-(trifluoromethyl)-；1-butan-2-yl-4-(trifluoromethyl)benzene
• CAS: 61628-76-0
• 化学式: C₁₁H₁₃F₃
• 分子量: 202.219
• InChiKey: DFRCPNBFPJBKBA-UHFFFAOYSA-N

物化性质

• 沸点：
  193.8±35.0 °C(Predicted)
• 密度：
  1.066±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-methyl-3-p-trifluoromethylphenylpropanol 生成 2-(p-Trifluormethylphenyl)-butan
  参考文献：
  名称：

  Organomagnesien reactif reducteur

  摘要：

  DOI：

  10.1016/s0022-328x(00)87330-1

文献信息

• Introducing a new radical trifluoromethylation reagent
  作者：Azusa Sato、Jianlin Han、Taizo Ono、Alicja Wzorek、José Luis Aceña、Vadim A. Soloshonok

  DOI：10.1039/c5cc00905g

  日期：——

  Radical trifluoromethylations of aromatic molecules have been achieved by using a persistent perfluoroalkyl radical as a precursor of the CF₃radical. The process works efficiently in terms of chemical yields to produce mixtures of regioisomeric trifluoromethylated compounds.

  芳香分子的基团三氟甲基化已通过使用持久的全氟烷基自由基作为CF3自由基的前体而实现。该过程在化学产率方面高效运作，产生混合的位置异构三氟甲基化合物。
• Nickel-Catalyzed Cross-Coupling of Alkyl Zinc Halides for the Formation of C(sp²)C(sp³) Bonds: Scope and Mechanism
  作者：Vilas B. Phapale、Manuel Guisán-Ceinos、Elena Buñuel、Diego J. Cárdenas

  DOI：10.1002/chem.200901913

  日期：2009.11.23

  Optimal conditions for a general Ni‐catalysed Negishi cross‐coupling of alkyl zinc halides with aryl, heteroaryl and alkenyl halides have been determined. These conditions allow the reaction to take place smoothly, with low catalyst loading, and in the presence of a wide variety of functional groups to afford products in good yields at room temperature. DFT studies on the mechanism support the occurrence

  确定了烷基锌卤化物与芳基，杂芳基和烯基卤化物的一般Ni催化Negishi交叉偶联的最佳条件。这些条件使得反应能够在低催化剂负载下并且在多种官能团的存在下平稳地进行，从而在室温下以高收率提供产物。在机构DFT研究支持的烷基卤化锌的催化循环中涉及转移金属化的发生，镍我随后氧化加成的卤代芳烃的和C  Ç还原消除。
• NITROGEN-CONTAINING HETEROCYCLES AS PESTICIDES
  申请人：Bayer CropScience Aktiengesellschaft

  公开号：US20180201600A1

  公开（公告）日：2018-07-19

  The present application relates to novel heterocyclic compounds, to processes and intermediates for the preparation thereof, and their use for controlling animal pests.

  本申请涉及新颖的杂环化合物，以及用于制备这些化合物的过程和中间体，以及它们用于控制动物害虫的用途。
• HETEROARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS
  申请人：Enanta Pharmaceuticals, Inc.

  公开号：US20180193352A1

  公开（公告）日：2018-07-12

  The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: These compounds are useful for treating Respiratory Syncytial Virus (RSV) infection. The present invention further relates to pharmaceutical compositions comprising these compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering to the subject a pharmaceutical composition comprising a compound of the invention.

  本发明公开了化合物I的结构，以及其药用可接受的盐、酯或前药：这些化合物对治疗呼吸道合胞病毒（RSV）感染有用。本发明还涉及包含这些化合物的药物组合物，用于给患有RSV感染的受试者使用。该发明还涉及通过向受试者给予包含本发明化合物的药物组合物来治疗受试者的RSV感染的方法。
• 3-(4-AMINOPHENYL)-2-FURANCARBOXYLIC ACID DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
  申请人：Fujii Akihito

  公开号：US20120059012A1

  公开（公告）日：2012-03-08

  Disclosed is a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof: wherein R 1 is 1: a C 3-8 cycloalkyl C 1-4 alkyl group, 2: a C 7-14 aralkyl group, in which the aryl moiety thereof is optionally substituted with the same or different 1 to 3 groups selected from the group consisting of: (a) halogen, (b) C 1-4 alkyl, which is optionally substituted with 1 to 3 fluorine atoms, (c) C 1-4 alkoxy, which is optionally substituted with 1 to 3 fluorine atoms, and (d) C 1-4 alkylcarbonyl, which is optionally substituted with C 1-4 alkoxy, 3: a five- to ten-membered heteroaryl-C 1-4 alkyl group, in which the heteroaryl moiety thereof is optionally substituted with the same or different 1 to 3 groups selected from the group consisting of: (a) halogen, and (b) C 1-4 alkyl, or 4: a C 6-10 aryl C 2-6 alkenyl group; and R 2 is a cyano group or a nitro group.

  揭示了由化学式（I）表示的化合物或其药学上可接受的盐：其中R1是1：C3-8环烷基C1-4烷基基团，2：C7-14芳基烷基基团，其中其芳基部分可选择性地取代为来自以下组成的1至3个相同或不同的基团：(a)卤素，(b)C1-4烷基，可选择性地取代为1至3个氟原子，(c)C1-4烷氧基，可选择性地取代为1至3个氟原子，和(d)C1-4烷基羰基，可选择性地取代为C1-4烷氧基，3：五元至十元杂芳基-C1-4烷基基团，其中其杂芳基部分可选择性地取代为来自以下组成的1至3个相同或不同的基团：(a)卤素，和(b)C1-4烷基，或4：C6-10芳基C2-6烯基基团；和R2是氰基或硝基基团。